Corrigendum: Regulatory T cells targeting a pathogenic MHC class II: insulin peptide epitope postpone spontaneous autoimmune diabetes

Corrigendum: Regulatory T cells targeting a pathogenic MHC class II: insulin peptide epitope postpone spontaneous autoimmune diabetes

Bibliographic Details
Main Authors:	Nyerhovwo Obarorakpor, Deep Patel, Reni Boyarov, Nansalmaa Amarsaikhan, Joseph Ray Cepeda, Doreen Eastes, Sylvia Robertson, Travis Johnson, Kai Yang, Qizhi Tang, Li Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-03-01
Series:	Frontiers in Immunology
Subjects:	Type 1 diabetes regulatory T cell chimeric antigen receptor antigen specific immunotherapy MHC II/Insulin complex monoclonal antibody
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1391518/full

Similar Items

Regulatory T cells targeting a pathogenic MHC class II: Insulin peptide epitope postpone spontaneous autoimmune diabetes
by: Nyerhovwo Obarorakpor, et al.
Published: (2023-08-01)

The Avian MHC-Antigen System
by: Diana Wesselinova
Published: (2002-10-01)

The yin/yang balance of the MHC-self-immunopeptidome
by: Laura Santambrogio, et al.
Published: (2022-11-01)

Peptide and Peptide-Dependent Motions in MHC Proteins: Immunological Implications and Biophysical Underpinnings
by: Cory M. Ayres, et al.
Published: (2017-08-01)

MHC-restricted antigen presentation and recognition: constraints on gene, recombinant and peptide vaccines in humans
by: Cunha-Neto E.
Published: (1999-01-01)

TAPBPR alters MHC class I peptide presentation by functioning as a peptide exchange catalyst
by: Clemens Hermann, et al.
Published: (2015-10-01)

Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I molecules
by: Georgia F. Papadaki, et al.
Published: (2023-01-01)

Tim-3 Relieves Experimental Autoimmune Encephalomyelitis by Suppressing MHC-II
by: Lili Tang, et al.
Published: (2022-01-01)

Toward a network model of MHC class II-restricted antigen processing
by: Laurence C Eisenlohr, et al.
Published: (2013-12-01)

Immune Evasion through Loss of MHC Class I Antigen Presentation
by: Annissa Ambaravista Nasution, et al.
Published: (2023-06-01)

DiscovEpi: automated whole proteome MHC-I-epitope prediction and visualization
by: C. Mahncke, et al.
Published: (2024-09-01)

The role of insulin-regulated aminopeptidase in MHC class I antigen presentation
by: Peter M Van Endert, et al.
Published: (2012-03-01)

Targeting the MHC Ligandome by Use of TCR-Like Antibodies
by: Lene Støkken Høydahl, et al.
Published: (2019-05-01)

A high-throughput yeast display approach to profile pathogen proteomes for MHC-II binding
by: Brooke D Huisman, et al.
Published: (2022-07-01)

The relationship between MHC−peptide interaction and resistance to virus in chickens
by: Yuan‐chang Jin, et al.
Published: (2022-03-01)

MHC class I-presented tumor antigen appraisable for T-cell responses against ovarian cancer
by: Jing Yao Wang, et al.
Published: (2015-07-01)

Organizing MHC Class II Presentation
by: David R Fooksman
Published: (2014-04-01)

Study on the contrast of the MHC–peptide interaction of B2/B21 haplotype and MHC‐related virus resistance in chickens
by: Yuan‐chang Jin, et al.
Published: (2021-12-01)

Therapeutic Potential of Cancer Vaccine Based on MHC Class I Cryptic Peptides Derived from Non-Coding Regions
by: Serina Tokita, et al.
Published: (2021-11-01)

1,2,3, MHC: a review of mass-spectrometry-based immunopeptidomics methods for relative and absolute quantification of pMHCs
by: L.E. Stopfer, et al.
Published: (2021-10-01)

Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
by: Karthik Dhatchinamoorthy, et al.
Published: (2021-03-01)

TAPBPR bridges UDP-glucose:glycoprotein glucosyltransferase 1 onto MHC class I to provide quality control in the antigen presentation pathway
by: Andreas Neerincx, et al.
Published: (2017-04-01)

NetMHCphosPan - Pan-specific prediction of MHC class I antigen presentation of phosphorylated ligands
by: Carina Thusgaard Refsgaard, et al.
Published: (2021-10-01)

Epithelial-myeloid exchange of MHC class II constrains immunity and microbiota composition
by: W. Zac Stephens, et al.
Published: (2021-11-01)

Chaperone-mediated MHC-I peptide exchange in antigen presentation
by: Jiansheng Jiang, et al.
Published: (2024-05-01)

Quantifying conformational changes in the TCR:pMHC-I binding interface
by: Benjamin McMaster, et al.
Published: (2024-12-01)

Antigen-specific T cell activation independently of the MHC: chimeric antigen receptor (CAR)-redirected T cells.
by: Hinrich eAbken, et al.
Published: (2013-11-01)

In silico and in vivo analysis of Toxoplasma gondii epitopes by correlating survival data with peptide–MHC-I binding affinities
by: Si-Yang Huang, et al.
Published: (2016-07-01)

Macropinocytosis in Phagocytes: Regulation of MHC Class-II-Restricted Antigen Presentation in Dendritic Cells
by: Zhenzhen eLiu, et al.
Published: (2015-01-01)

Expression of Functional MHC Class II Molecules By aMouse Pro-B Cell Clone
by: Suzanne Lombard-Platet, et al.
Published: (1995-01-01)

How ERAP1 and ERAP2 Shape the Peptidomes of Disease-Associated MHC-I Proteins
by: José A. López de Castro
Published: (2018-10-01)

Chimeric antigen receptor T-cell therapy for T-ALL and AML
by: Wenwen Wei, et al.
Published: (2022-11-01)

IRF2 loss is associated with reduced MHC I pathway transcripts in subsets of most human cancers and causes resistance to checkpoint immunotherapy in human and mouse melanomas
by: G. Sari, et al.
Published: (2024-10-01)

Escape from the phagosome: the explanation for MHC-I processing of mycobacterial antigens?
by: Melanie eHarriff, et al.
Published: (2012-03-01)

HLA-DO and its role in MHC Class II antigen presentation
by: Yuri O Poluektov, et al.
Published: (2013-08-01)

Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects
by: Xiangyu Wu, et al.
Published: (2023-12-01)

The Intracellular Proteome as a Source for Novel Targets in CAR-T and T-Cell Engagers-Based Immunotherapy
by: Inbar Arman, et al.
Published: (2022-12-01)

Trans-Allelic Model for Prediction of Peptide:MHC-II Interactions
by: Abdoelnaser M. Degoot, et al.
Published: (2018-06-01)

Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I
by: Owen Leddy, et al.
Published: (2023-04-01)

THERMODYNAMICS OF PEPTIDE-MHC CLASS II INTERACTIONS: NOT ALL COMPLEXES ARE CREATED EQUAL
by: Andrea eFerrante
Published: (2013-10-01)